Telcare gets $25.4mm in first close of Series B
Glucose monitoring device developer Telcare Inc. has raised $25.4mm in the first close of its Series B financing led by new investor Sequoia Capital with participation from returning shareholder Qualcomm (through its Qualcomm Life Fund) and undisclosed investors. According to the Form D, the company could bring in another $13.1mm in the round.
- Medical Devices
- Diagnostic Equipment & Supplies
In Vitro Diagnostics
- Glucose Testing
- Venture Financing
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.